Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Meredith

Showing results (321-330 of 444) with videos related to

Pageof 45
Sort By:
Clinical Pharmacokinetics|March 1, 1985
Clinical pharmacokinetics of prazosin--1985J Vincent, P A Meredith, J L Reid, et al.
Clinical Pharmacology and Therapeutics|December 1, 1984
Combined alpha adrenoceptor antagonism and calcium channel blockade in normal subjectsF Pasanisi, H L Elliott, P A Meredith, et al.
Journal of Cardiovascular Pharmacology|April 1, 1992
Combination of nifedipine and doxazosin in essential hypertensionR Donnelly, H L Elliott, P A Meredith, et al.
British Journal of Clinical Pharmacology|May 1, 1984
Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist propertiesH L Elliott, K McLean, P A Meredith, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosinR Donnelly, H L Elliott, P A Meredith, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Factors determining the response to calcium antagonists in hypertensionR Donnelly, J L Reid, P A Meredith, et al.
Current Medical Research and Opinion|September 18, 2012
Are fixed-dose combination antihypertensives suitable as first-line therapy?Sverre E Kjeldsen, Franz H Messerli, Chern-En Chiang, et al.
Circulation|November 17, 1998
ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humansS Ueda, P A Meredith, J J Morton, et al.
American Journal of Ophthalmology|June 1, 1978
The prevalence of HLA-B7 in presumed ocular histoplasmosisR E Braley, T A Meredith, T M Aaberg, et al.
American Journal of Therapeutics|August 1, 1995
Effects of Age on the Pharmacokinetics and Pharmacodynamics of Cardiovascular Drugs: Application of Concentration-Effect Modeling. 3. TrimazosinP. A. Meredith, P. J.W. Scott, A. W. Kelman, et al.
Pageof 45

Showing results (321-330 of 444) with videos related to

Sort By:
Pageof 45
Clinical Pharmacokinetics|March 1, 1985
Clinical pharmacokinetics of prazosin--1985J Vincent, P A Meredith, J L Reid, et al.
Clinical Pharmacology and Therapeutics|December 1, 1984
Combined alpha adrenoceptor antagonism and calcium channel blockade in normal subjectsF Pasanisi, H L Elliott, P A Meredith, et al.
Journal of Cardiovascular Pharmacology|April 1, 1992
Combination of nifedipine and doxazosin in essential hypertensionR Donnelly, H L Elliott, P A Meredith, et al.
British Journal of Clinical Pharmacology|May 1, 1984
Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist propertiesH L Elliott, K McLean, P A Meredith, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosinR Donnelly, H L Elliott, P A Meredith, et al.
Journal of Cardiovascular Pharmacology|January 1, 1988
Factors determining the response to calcium antagonists in hypertensionR Donnelly, J L Reid, P A Meredith, et al.
Current Medical Research and Opinion|September 18, 2012
Are fixed-dose combination antihypertensives suitable as first-line therapy?Sverre E Kjeldsen, Franz H Messerli, Chern-En Chiang, et al.
Circulation|November 17, 1998
ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humansS Ueda, P A Meredith, J J Morton, et al.
American Journal of Ophthalmology|June 1, 1978
The prevalence of HLA-B7 in presumed ocular histoplasmosisR E Braley, T A Meredith, T M Aaberg, et al.
American Journal of Therapeutics|August 1, 1995
Effects of Age on the Pharmacokinetics and Pharmacodynamics of Cardiovascular Drugs: Application of Concentration-Effect Modeling. 3. TrimazosinP. A. Meredith, P. J.W. Scott, A. W. Kelman, et al.
Pageof 45